PML, a Growth Suppressor Disrupted in Acute Promyelocytic Leukemia

REFERENCES

• Alcalay, M. D., D. Zangrilli, P. Paolo, L. Longo, A. Mencarelli, A. Giacomucci, M. Rocchi, A. Biondi, A. Rambaldi, F. LoCoco, D. Diverio, E. Donti, F. Grignani, and P. G. Pelicci. 1991. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor a locus. Proc. Natl. Acad. Sci. USA 88:1977–1981.
   PubMed Web of Science ®Google Scholar
• Berg, J. M. 1990. Zinc fingers and other metal-binding domains: elements for interactions between macromolecules. J. Biol. Chem. 265:6513–6516.
   PubMed Web of Science ®Google Scholar
• Berger, R., M. Leconiat, J. Derr, D. Vecchione, and P. Jonveaux. 1991. Cytogenetic studies in acute promyelocytic leukemia: a survey of secondary chromosomal abnormalities. Genes Chromosomes Cancer 3:332–337.
   PubMed Web of Science ®Google Scholar
• Borrow, J., A. D. Goddard, D. Sheer, and E. Solomon. 1990. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577–1580.
   PubMed Web of Science ®Google Scholar
• Castaigne, S., C. Chomienne, M. T. Daniel, P. Ballerini, R. Berger, P. Fenaux, and L. Degos. 1990. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704–1709.
   PubMed Web of Science ®Google Scholar
• Chang, K. S., J. Lu, J. M. Trujillo, E. Estey, A. Cork, G. Wang, E. Freireich, and S. A. Stass. 1992. The t(15;17) breakpoint in acute promyelocytic leukemia clusters within two different sites of the myl gene: targets for the detection of minimal residual disease by polymerase chain reaction. Blood 79:554–558.
   PubMed Web of Science ®Google Scholar
• Chang, K. S., S. A. Stass, D. T. Chu, L. L. Deaven, J. M. Trujillo, and E. Freireich. 1992. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol. Cell. Biol. 12:800–810.
   PubMed Web of Science ®Google Scholar
• Chang, K. S., J. M. Trujillo, T. Ogura, C. M. Castiglione, K. K. Kidd, S. Zhao, E. Freireich, and S. A. Stass. 1991. Rearrangement of the retinoic acid receptor gene in acute promyelocytic leukemia. Leukemia 5:200–204.
   PubMed Web of Science ®Google Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Chen, S., Y. Zhu, J. Tong, S. Dong, W. Huang, Y. Chen, W. Ziang, L. Zhang, X. Li, G. Qian, Z. Wang, Z. Chen, C. Larsen, and R. Berger. 1991. Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid-induced leukemic cell differentiation. Blood 78:2696–2701.
   PubMed Web of Science ®Google Scholar
• Chen, T. M., and V. Defendi. 1992. Functional interaction of p53 with HPV18E6, c-myc and H-ras in 3T3 cells. Oncogene 7:1541–1547.
   PubMedGoogle Scholar
• Chin, K. V., K. Ueda, I. Pastan, and M. M. Gottesman. 1991. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459–462.
   Web of Science ®Google Scholar
• Chomienne, C., P. Ballerini, N. Balitrand, M. T. Daniel, P. Fenaux, S. Castaigne, and L. Degos. 1990. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 76:1710–1717.
   PubMed Web of Science ®Google Scholar
• Chomienne, C., P. Ballerini, N. Balitrand, M. E. Huang, I. Krawice, S. Castaigne, P. Fenaux, P. Tiollais, A. Dejean, L. Degos, and H. de The. 1990. The retinoic acid receptor α gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia 4:802–807.
   PubMed Web of Science ®Google Scholar
• Daniel, M. T., M. Koken, O. Romagne, S. Barbey, A. Bazarbachi, M. Stadler, M. C. Guillemin, L. Degos, C. Chomienne, and H. de The. 1993. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858–1867.
   PubMed Web of Science ®Google Scholar
• Dermime, S., F. Grignani, M. Clerici, C. Nervi, G. Sozzi, G. P. Talamo, E. Marchesi, F. Formelli, G. Parmiani, P. G. Pelicci, and C. G. Passerini. 1993. Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood 82:1573–1577.
   PubMed Web of Science ®Google Scholar
• de The, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature (London) 347:558–561.
   PubMed Web of Science ®Google Scholar
• de The, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARA fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675–684.
   PubMed Web of Science ®Google Scholar
• Doucas, V., J. P. Brockes, M. Yaniv, H. de The, and A. Dejean. 1993. The PML-retinoic acid receptor a translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. Proc. Natl. Acad. Sci. USA 90:9345–9349.
   PubMedGoogle Scholar
• Dyck, J. A., G. G. Maul, W. H. Miller, Jr., J. D. Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:332–343.
   Google Scholar
• Eglitis, M. A., and W. F. Anderson. 1988. Retroviral vector for introduction of genes into mammalian cells. BioTechniques 6:608–614.
   PubMed Web of Science ®Google Scholar
• Eglitis, M. A., P. W. Kantoff, E. Gilboa, and W. F. Anderson. 1985. Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science 230:1395–1398.
   PubMed Web of Science ®Google Scholar
• Fagioli, M., M. Alcalay, P. P. Pandolfi, L. Venturini, A. Mencarelli, A. Simeone, D. Acampora, F. Grignani, and P. G. Pelicci. 1992. Alternative splicing of PML transcripts predicts coexpression of several carboxyl-terminally different protein isoforms. Oncogene 7:1083–1091.
   PubMedGoogle Scholar
• Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093.
   PubMed Web of Science ®Google Scholar
• Freemont, P. S., I. M. Hanson, and J. Trowsdale. 1991. A novel cysteine-rich sequence motif. Cell 64:483–484.
   PubMed Web of Science ®Google Scholar
• Giguere, V., E. S. Ong, P. Sequi, and R. M. Evan. 1987. Identification of a receptor for the morphogen retinoic acid. Nature (London) 330:624–629.
   PubMed Web of Science ®Google Scholar
• Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979–9983.
   PubMed Web of Science ®Google Scholar
• Goddard, A., J. Borrow, P. S. Freemont, and E. Solomon. 1991. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254:1371–1374.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., G. T. Merlino, M. C. Willingham, I. Pastan, and B. H. Howard. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci. USA 79:6777–6781.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Green, S., I. Issemann, and E. Sheer. 1988. A versatile in vivo eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:369.
   PubMedGoogle Scholar
• Grignani, F., P. F. Ferrucci, U. Testa, G. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, C. Peschle, I. Nicoletti, and P. G. Pelicci. 1993. The acute promyelocytic leukemia-specific PML-RARa fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423–431.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., C. A. Finlay, A. B. Frey, and A. J. Levine. 1987. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol. 7:2863–2869.
   PubMed Web of Science ®Google Scholar
• Huang, M., Y. C. Ye, B. R. Chen, J. R. Chai, J. X. Lu, L. Zhoa, L. J. Gu, and Z. Y. Wang. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567–572.
   PubMed Web of Science ®Google Scholar
• Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249–270.
   PubMed Web of Science ®Google Scholar
• Ishii, S., Y.-H. Xu, R. H. Stratton, B. A. Roe, G. T. Merlino, and I. Pastan. 1985. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA 82:4920–4924.
   PubMedGoogle Scholar
• Kakizuka, A., W. H. Miller, K. Umesono, R. P. Warrell, S. R. Frankel, V. V. V. S. Murty, E. Dmitrovsky, and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARA with a novel putative transcription factor, PML. Cell 66:663–674.
   PubMed Web of Science ®Google Scholar
• Kastner, P., and P. Chambon. Personal communication.
   Google Scholar
• Kastner, P., A. Perez, Y. Lutz, C. Rochette-Egly, M. P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11:629–642.
   PubMed Web of Science ®Google Scholar
• Kim, S. J., H. D. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and A. B. Roberts. 1991. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl. Acad. Sci. USA 88:3052–3056.
   PubMed Web of Science ®Google Scholar
• Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. A. Weinberg. 1986. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6:1917–1925.
   PubMed Web of Science ®Google Scholar
• Lanotte, M., V. Martin-Thouvenin, S. Najman, P. Ballerini, F. Valensi, and R. Berger. 1991. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080–1086.
   PubMed Web of Science ®Google Scholar
• Larson, R. A., K. Kondo, J. W. Wardiman, A. E. Butler, Η. M. Golom, and J. D. Rowley. 1984. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am. J. Med. 76:827–841.
   PubMed Web of Science ®Google Scholar
• Longo, L., D. Trecca, A. Biondi, F. LoCoco, F. Grignani, M. A. Maiolo, P. G. Pelicci, and A. Neri. 1993. Frequency of RAS and p53 mutations in acute promyelocytic leukemia. Leuk. Lymphoma 11:405–410.
   PubMed Web of Science ®Google Scholar
• Markovitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer separating viral genes on two different plasmids. J. Virol. 62:1120–1124.
   PubMedGoogle Scholar
• Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980–990.
   PubMed Web of Science ®Google Scholar
• Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245–247.
   PubMed Web of Science ®Google Scholar
• Pandolfi, P. P., M. Alcalay, M. Fagioli, D. Zangrilli, A. Mencarelli, D. Diverio, A. Biondi, F. LoCoco, A. Rambaldi, F. Grignani, C. Rochette-Egly, M. P. Gaube, P. Chambon, and P. G. Pelicci. 1992. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in APL. EMBO J. 11:1397–1407.
   PubMed Web of Science ®Google Scholar
• Pandolfi, P. P., M. Alcalay, A. Mencarelli, A. Biondi, F. LoCoco, F. Grignani, and P. G. Pelicci. 1991. Structure and origin of the acute promyelocytic leukemia myl/RARA cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285–1292.
   PubMed Web of Science ®Google Scholar
• Perez, A., P. Kastner, S. Sethi, Y. Lutz, C. Reibel, and P. Chambon. 1993. PML/RAR homodimers: distinct DNA binding properties and heteromeric interaction with RXR. EMBO J. 12:3171–3182.
   PubMed Web of Science ®Google Scholar
• Quitschke, W. W., Z.-Y. Lin, L. Deponti-Zilli, and B. M. Paterson. 1989. The β actin promoter: high levels of transcription depend upon a CCAAT binding factor. J. Biol. Chem. 264:9539–9546.
   PubMedGoogle Scholar
• Raycroft, L., H. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 antioncogene. Science 249:1049–1051.
   PubMed Web of Science ®Google Scholar
• Reichel, H., and A. W. Norman. 1989. Systemic effects of vitamin D. Annu. Rev. Med. 40:71–78.
   PubMed Web of Science ®Google Scholar
• Reichlin, M. 1980. Use of glutaraldehyde as a coupling agent for proteins and peptides. Methods Enzymol. 70:159–165.
   PubMedGoogle Scholar
• Robbins, P. D., J. M. Horowitz, and R. C. Mulligan. 1990. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature (London) 46:668–671.
   Google Scholar
• Robertson, K. A., B. Emami, L. Mueller, and S. J. Collins. 1992. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol. Cell. Biol. 12:3743–3749.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Sawyers, C. L., C. T. Denny, and Ο. N. Witte. 1991. Leukemia and the disruption of normal hematopoiesis. Cell 64:337–350.
   PubMed Web of Science ®Google Scholar
• Sleigh, M. J. 1986. A non-chromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal. Biochem. 156:251–256.
   PubMed Web of Science ®Google Scholar
• Tanaka, Η., E. Abe, C. Miyaura, T. Kuribayashi, K. Konno, Y. Nishii, and T. Suda. 1982. 1-Alpha, 25-dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem. J. 204:713–719.
   PubMed Web of Science ®Google Scholar
• Tsai, S., and S. J. Collins. 1993. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc. Natl. Acad. Sci. USA 90:7153–7157.
   PubMed Web of Science ®Google Scholar
• Warrell, R. P., S. P. Frankel, W. H. Miller, D. A. Scheiberg, L. M. Itri, W. M. Hittelman, R. Vyas, M. Andreef, A. Tafuri, A. Jakubowski, J. Gabrilove, M. S. Gordon, and E. Dmitrovsky. 1991. Differentiation therapy of acute promyelocytic leukemia with tretinoin (All-Trans-retinoic acid). N. Engl. J. Med. 324:1385–1393.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1989. Oncogenes and multistep carcinogenesis, p. 307–326. In R. Weinberg (ed.), Oncogenes and the molecular origins of cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345–356.
   PubMed Web of Science ®Google Scholar
• Yamamoto, K., S. Hirosawa, H. Sakamaki, and N. Aoki. 1992. Frequent rearrangements of retinoic acid receptor alpha gene and myl gene, and rare mutations of RAS and FMS genes in acute promyelocytic leukemia. Am. J. Hematol. 40:252–258.
   PubMed Web of Science ®Google Scholar
• Yu, D., A. Matin, and M. C. Hung. 1992. The retinoblastoma gene product suppresses neu oncogene-induced transformation via transcriptional repression of neu. J. Biol. Chem. 267:10203–10206.
   PubMedGoogle Scholar